DREAM Award

Characterizing the user of anticoagulants in children using the ATHNdataset

Authors:
Davila, J., Cheng, D., Raffini, L., Thornburg, C., Corrales-Medina, F.
Publication:
Thrombosis Research
Date:
January 2021
Topics:
Thrombosis, DOAC

Letter to the Editor: Management of inhibitors in persons with non-sever hemophilia A in the United States

Authors:
Lim, M., Cheng, D., Recht, M., Kempton, CL., Key, N.
Publication:
American Journal of Hematology
Date:
October 13, 2020
Topics:
Hemophilia, Inhibitor

Mortality in Non-Severe Hemophilia A

Authors:
Lim, M., Recht, M., Kempton, C., Cheng, D., Key, N.
Publication:
American Journal of Hematology
Date:
October 2, 2020
Topics:
Hemophilia, Mortality

Management of inhibitors in non-severe hemophilia A patients in the United States: A multicenter, registry-based, observational study

Authors:
Lim, M., Cheng, D., Kempton, C., Key, N.
Publication:
World Hemophilia Foundation (WFH) Virtual Summit
Date:
June 14-19, 2020
Topics:
Hemophila, Registry

The Impact of Extended Half-Life Factor Concentrates on Prophylaxis for Severe Hemophilia in The United States

Authors:
Malec, L., Cheng, D., Witmer, C., Jaffray, J., Kouides, P., Haley, K., Sidonio, R., Johnson, K., Recht, M., White, G., Croteau, S., Ragni, M.
Publication:
American Journal of Hematology; 95(8)
Date:
April 30, 2020
Topics:
Hemophilia, Factor